DE69610792T2 - Inhibitoren mit zweifacher Wirkung, die 1,2-Diazepin enthalten - Google Patents
Inhibitoren mit zweifacher Wirkung, die 1,2-Diazepin enthaltenInfo
- Publication number
- DE69610792T2 DE69610792T2 DE69610792T DE69610792T DE69610792T2 DE 69610792 T2 DE69610792 T2 DE 69610792T2 DE 69610792 T DE69610792 T DE 69610792T DE 69610792 T DE69610792 T DE 69610792T DE 69610792 T2 DE69610792 T2 DE 69610792T2
- Authority
- DE
- Germany
- Prior art keywords
- diazepine
- double
- inhibitors containing
- acting inhibitors
- chem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47404195A | 1995-06-07 | 1995-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69610792D1 DE69610792D1 (de) | 2000-12-07 |
DE69610792T2 true DE69610792T2 (de) | 2001-06-13 |
Family
ID=23881962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69610792T Expired - Fee Related DE69610792T2 (de) | 1995-06-07 | 1996-05-28 | Inhibitoren mit zweifacher Wirkung, die 1,2-Diazepin enthalten |
Country Status (11)
Country | Link |
---|---|
US (1) | US5635504A (de) |
EP (1) | EP0747392B1 (de) |
JP (1) | JPH08337527A (de) |
AT (1) | ATE197306T1 (de) |
AU (1) | AU696673B2 (de) |
CA (1) | CA2178355A1 (de) |
DE (1) | DE69610792T2 (de) |
DK (1) | DK0747392T3 (de) |
ES (1) | ES2151977T3 (de) |
GR (1) | GR3035239T3 (de) |
PT (1) | PT747392E (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587375A (en) * | 1995-02-17 | 1996-12-24 | Bristol-Myers Squibb Company | Azepinone compounds useful in the inhibition of ACE and NEP |
US5877313A (en) | 1995-05-17 | 1999-03-02 | Bristol-Myers Squibb | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
DE19750002A1 (de) * | 1997-11-12 | 1999-05-20 | Solvay Pharm Gmbh | Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6340752B1 (en) | 1998-01-06 | 2002-01-22 | Bristol-Myers Squibb Co. | Deprotection and recrystallization processes |
JP4499917B2 (ja) * | 1998-03-09 | 2010-07-14 | バーテックス ファーマシューティカルズ インコーポレイテッド | インターロイキン−1β変換酵素のインヒビターとしての1,2−ジアゼパン誘導体 |
WO2001055074A1 (fr) | 2000-01-25 | 2001-08-02 | Kaneka Corporation | Processus de production d'acide carboxylique optiquement actif substitue en position 2 |
EP1138671B1 (de) * | 2000-03-30 | 2004-09-01 | Ajinomoto Co., Inc. | Verfahren zur Herstellung von aromatischen Acylthiocarbonsäurederivaten |
EP1275642A4 (de) * | 2000-04-21 | 2004-12-08 | Kaneka Corp | Ein verfahren zur kristallisation von 2-acethylthio-3-phenyl-propansäure |
NL1015714C2 (nl) * | 2000-07-14 | 2002-01-15 | Dsm Nv | Werkwijze voor het kristalliseren van enantiomeer verrijkt 2-acetylthio-3-fenylpropaanzuur. |
JP4718534B2 (ja) * | 2007-11-09 | 2011-07-06 | カルピス株式会社 | Fischer比低下抑制剤 |
CA2772877A1 (en) * | 2009-09-01 | 2011-03-10 | Lz Therapeutics, Inc. | Treatment of glaucoma and other retinopathies with gangliosides |
EP2473615B1 (de) | 2009-09-01 | 2016-04-06 | LZ Therapeutics, Inc. | Herstellung von GM1 durch Zellkulturen (nicht vom Rind oder Schwein) |
US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
US9556467B2 (en) | 2012-01-20 | 2017-01-31 | Garnet Bio Therapeutics, Inc. | Methods of ganglioside production |
CN102805751B (zh) * | 2012-08-27 | 2014-07-02 | 澳门科技大学 | 治疗心脑血管疾病的药物组合物及其制备方法 |
EP3672939A1 (de) | 2017-08-21 | 2020-07-01 | Celgene Corporation | Verfahren zur herstellung von (s)-tert-butyl 4,5-diamino-5-oxopentanoat |
CN109111371B (zh) * | 2018-09-27 | 2021-08-06 | 江西万里药业有限公司 | 一种肼基乙酸乙酯盐酸盐的制备方法 |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2210633C2 (de) * | 1972-03-06 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4339600A (en) * | 1976-05-10 | 1982-07-13 | E. R. Squibb & Sons, Inc. | Compounds for alleviating angiotensin related hypertension |
FR2358891A1 (fr) * | 1976-07-22 | 1978-02-17 | Yamanouchi Pharma Co Ltd | Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires |
US4225495A (en) * | 1978-12-07 | 1980-09-30 | E. R. Squibb & Sons, Inc. | Pyrrolo or pyrido [2,1-c][1,4] thiazines or thiazepines |
US4192945A (en) * | 1978-12-07 | 1980-03-11 | E. R. Squibb & Sons, Inc. | Process for preparing proline and homoproline derivatives |
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
US4680392A (en) * | 1980-08-18 | 1987-07-14 | Merck & Co., Inc. | Substituted caprolactam derivatives as antihypertensives |
US4629787A (en) * | 1980-08-18 | 1986-12-16 | Merck & Co., Inc. | Substituted caprolactam derivatives as antihypertensives |
US4587050A (en) * | 1980-08-18 | 1986-05-06 | Merck & Co., Inc. | Substituted enantholactam derivatives as antihypertensives |
US4409146A (en) * | 1980-10-06 | 1983-10-11 | Merck & Co., Inc. | Substituted caprolactam derivatives as antihypertensives |
US4337201A (en) * | 1980-12-04 | 1982-06-29 | E. R. Squibb & Sons, Inc. | Phosphinylalkanoyl substituted prolines |
US4415496A (en) * | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
US4587238A (en) * | 1981-07-06 | 1986-05-06 | Merck & Co., Inc. | Substituted caprylolactam derivatives as anti-hypertensives |
US4432971A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4432972A (en) * | 1981-08-03 | 1984-02-21 | E. R. Squibb & Sons, Inc. | Phosphonamidate compounds |
US4410520A (en) * | 1981-11-09 | 1983-10-18 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
US4594341A (en) * | 1982-04-06 | 1986-06-10 | Merck & Co., Inc. | Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives as antihypertensives |
GB2128984B (en) * | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
US4873235A (en) * | 1982-06-01 | 1989-10-10 | Merck & Co., Inc. | Benzofused lactams as antihypertensives |
US4473575A (en) * | 1982-07-19 | 1984-09-25 | Ciba-Geigy Corporation | 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids |
US4465679A (en) * | 1983-01-31 | 1984-08-14 | Usv Pharmaceutical Corporation | 1,2-Diaza-3-one compounds, their use in treating hypertension and pharmaceutical compositions thereof |
FR2540495B1 (fr) * | 1983-02-07 | 1986-02-14 | Roussel Uclaf | Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus |
US4470988A (en) * | 1983-02-10 | 1984-09-11 | Ciba-Geigy Corporation | Benzazocinone and benzazoninone derivatives, and their pharmaceutical use |
US4537885A (en) * | 1983-02-10 | 1985-08-27 | Ciba Geigy Corporation | Certain benzazocinone and benzazoninone derivatives |
US4575503A (en) * | 1983-02-10 | 1986-03-11 | Ciba-Geigy Corporation | 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids |
US4477464A (en) * | 1983-02-10 | 1984-10-16 | Ciba-Geigy Corporation | Hetero-benzazepine derivatives and their pharmaceutical use |
US4711884A (en) * | 1983-02-28 | 1987-12-08 | E. R. Squibb & Sons, Inc. | Thiazine and thiazepine containing compounds |
US4460579A (en) * | 1983-02-28 | 1984-07-17 | E. R. Squibb & Sons, Inc. | Thiazine and thiazepine containing compounds |
US4617301A (en) * | 1983-06-22 | 1986-10-14 | Merck & Co., Inc. | Sulfoxide and sulfone derivatives of bicyclic lactams as antihypertensives |
US4539150A (en) * | 1983-06-29 | 1985-09-03 | Mitsui Toatsu Chemicals, Inc. | Benzothiazepine derivatives and their methods of preparation |
IL72523A (en) * | 1983-08-12 | 1988-06-30 | Takeda Chemical Industries Ltd | 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them |
US4722810A (en) * | 1984-08-16 | 1988-02-02 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
US4699905A (en) * | 1984-04-10 | 1987-10-13 | Sankyo Company, Limited | Perhydrothiazepine derivatives, their preparation and their therapeutic use |
US5238924A (en) * | 1984-05-03 | 1993-08-24 | Merck & Co., Inc. | Treatment of renal diseases with ace inhibitors |
US4584294A (en) * | 1984-11-07 | 1986-04-22 | Merck & Co., Inc. | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
JPH0637473B2 (ja) * | 1985-10-11 | 1994-05-18 | 三共株式会社 | ラクタム化合物 |
ZA874106B (en) * | 1986-06-13 | 1987-12-08 | Merrell Dow Pharmaceuticals Inc. | Novel antihypertensive agent |
US4973585A (en) * | 1986-06-13 | 1990-11-27 | Merrell Dow Pharmaceuticals | Tricyclic lactams active as antihypertensive agents |
CA1337654C (en) * | 1986-06-13 | 1995-11-28 | Gary A. Flynn | Fused tricyclic lactams as antihypertensive agents |
EP0254032A3 (de) * | 1986-06-20 | 1990-09-05 | Schering Corporation | Hemmer der neutralen Metallendopeptidase zur Behandlung von Hypertension |
US4749688A (en) * | 1986-06-20 | 1988-06-07 | Schering Corporation | Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension |
US4801609B1 (en) * | 1987-03-27 | 1993-11-09 | Mercapto-acylamino acid antihypertensives | |
US5262436A (en) * | 1987-03-27 | 1993-11-16 | Schering Corporation | Acylamino acid antihypertensives in the treatment of congestive heart failure |
CA1337400C (en) * | 1987-06-08 | 1995-10-24 | Norma G. Delaney | Inhibitors of neutral endopeptidase |
US4963539A (en) * | 1987-09-10 | 1990-10-16 | E. R. Squibb & Sons, Inc. | Phosphonate and phosphonamide endopeptidase inhibitors |
US4824832A (en) * | 1987-12-30 | 1989-04-25 | Merrell Dow Pharmaceuticals Inc. | Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
US4879309A (en) * | 1988-09-27 | 1989-11-07 | Schering Corporation | Mercapto-acylamino acids as antihypertensives |
US5075302A (en) * | 1990-03-09 | 1991-12-24 | Schering Corporation | Mercaptoacyl aminolactam endopeptidase inhibitors |
US5223516A (en) * | 1990-03-22 | 1993-06-29 | E. R. Squibb & Sons, Inc. | 3,3,3-trifluoro-2-mercaptomethyl-N-tetrazolyl substituted propanamides and method of using same |
FR2664269B1 (fr) * | 1990-07-05 | 1992-10-02 | Roussel Uclaf | Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant. |
CA2053340C (en) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US5232920A (en) * | 1990-12-21 | 1993-08-03 | Schering Corporation | N-(mercaptoalkyl)amides |
FR2679564A1 (fr) * | 1991-07-23 | 1993-01-29 | Inst Nat Sante Rech Med | Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent. |
US5225401A (en) * | 1991-08-12 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Treatment of congestive heart failure |
EP0534363B1 (de) * | 1991-09-27 | 1997-07-09 | Merrell Pharmaceuticals Inc. | 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung |
AU657793B2 (en) * | 1991-09-27 | 1995-03-23 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
CA2078759C (en) * | 1991-09-27 | 2003-09-16 | Alan M. Warshawsky | Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
NZ246811A (en) * | 1992-02-14 | 1996-02-27 | Merrell Dow Pharma | N-[pyrido (and oxazino and thiazino) benzazepine] 1-benzyl-1-(heterocyclyl(alkyl)carbonylthio) acetamide derivatives and pharmaceutical compositions |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
JP3360079B2 (ja) * | 1992-05-15 | 2002-12-24 | メレルダウファーマスーティカルズ インコーポレイテッド | エンケファリナーゼ及びACEの阻害剤として有用な新規なメルカプトアセチルアミドピリダゾ[1,2]ピリダジン、ピラゾロ[1,2]ピリダジン、ピリダゾ[1,2‐a][1,2]ジアゼピン、及びピラゾロ[1,2‐a][1,2]ジアゼピン誘導体類 |
RU2124503C1 (ru) * | 1992-05-18 | 1999-01-10 | И.Р.Сквибб энд Санз, Инк. | Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция |
US5208236A (en) * | 1992-09-23 | 1993-05-04 | Schering Corporation | N-(acylaminomethyl)glutaryl amino acids and use |
US5504080A (en) * | 1992-10-28 | 1996-04-02 | Bristol-Myers Squibb Co. | Benzo-fused lactams |
DE69329701T2 (de) * | 1992-10-30 | 2001-05-10 | Merrell Pharma Inc | Mercaptoacetylamid substituiertes bizyclisches laktam zur verwendung als enkephalinase und ace-hemmer |
GB9310075D0 (en) * | 1993-05-17 | 1993-06-30 | Fujisawa Pharmaceutical Co | New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
EP0671172A4 (de) * | 1993-06-11 | 1998-09-02 | Eisai Co Ltd | Aminosäurederivat. |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
US5362727A (en) * | 1993-07-26 | 1994-11-08 | Bristol-Myers Squibb | Substituted azepino[2,1-a]isoquinoline compounds |
US5525723A (en) * | 1993-11-18 | 1996-06-11 | Bristol-Myers Squibb Co. | Compounds containing a fused multiple ring lactam |
-
1996
- 1996-03-01 US US08/609,184 patent/US5635504A/en not_active Expired - Lifetime
- 1996-05-28 EP EP96108439A patent/EP0747392B1/de not_active Expired - Lifetime
- 1996-05-28 AT AT96108439T patent/ATE197306T1/de not_active IP Right Cessation
- 1996-05-28 PT PT96108439T patent/PT747392E/pt unknown
- 1996-05-28 DK DK96108439T patent/DK0747392T3/da active
- 1996-05-28 DE DE69610792T patent/DE69610792T2/de not_active Expired - Fee Related
- 1996-05-28 ES ES96108439T patent/ES2151977T3/es not_active Expired - Lifetime
- 1996-06-06 AU AU54760/96A patent/AU696673B2/en not_active Ceased
- 1996-06-06 JP JP8144101A patent/JPH08337527A/ja not_active Withdrawn
- 1996-06-06 CA CA002178355A patent/CA2178355A1/en not_active Abandoned
-
2001
- 2001-01-15 GR GR20010400055T patent/GR3035239T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3035239T3 (en) | 2001-04-30 |
PT747392E (pt) | 2001-02-28 |
JPH08337527A (ja) | 1996-12-24 |
EP0747392B1 (de) | 2000-11-02 |
AU696673B2 (en) | 1998-09-17 |
AU5476096A (en) | 1996-12-19 |
DE69610792D1 (de) | 2000-12-07 |
ES2151977T3 (es) | 2001-01-16 |
US5635504A (en) | 1997-06-03 |
EP0747392A1 (de) | 1996-12-11 |
DK0747392T3 (da) | 2001-01-29 |
CA2178355A1 (en) | 1996-12-08 |
ATE197306T1 (de) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69610873T2 (de) | Thiazolobenzazepin-enthaltende Inhibitoren mit zweifacher Wirkung | |
DE69610792D1 (de) | Inhibitoren mit zweifacher Wirkung, die 1,2-Diazepin enthalten | |
ES2127397T3 (es) | Sulfonamidas y sus derivados que modulan la actividad de la endotelina. | |
DK0629627T3 (da) | Bicykliske carboxylsyrer og derivater deraf som NEP- og ACA-inhibitorer | |
DE69104071D1 (de) | Uracilderivate und Pestizide, die diese als wirksame Stoffe enthalten. | |
ATE177082T1 (de) | N-heteroarylamidederivate als inhibitoren von acyl-coenzym a: cholesterol-acyl-transferase | |
AR038429A2 (es) | Compuestos 15-alquil-16-hidroxilo de marcfortina | |
ES2101960T3 (es) | Lactamas benzo-condensadas. | |
DE69623806T2 (de) | Pestizide | |
KR950701615A (ko) | 혈소판 응집 저해작용을 갖는 신규한 화합물(novel compound with plate-let aggregation inhibitor activity) | |
DE69126612D1 (de) | Carbamate des indan-pyrrolidins | |
ATE114309T1 (de) | N-azabicyclo(3.3.0>octanamide von aromatischen säuren. | |
DK0645374T3 (da) | 5-Amino-2-phenoxylsulfonanilidforbindelse | |
BR9306924A (pt) | Derivados de 1,3-oxazolidina pirdil-substituídos oidetos de 1,2,4-ditioz lio de novos compostos de partida | |
TH13552A (th) | อนุพันธุ์ต่าง ๆ ของเบนโซฟิโนน | |
ATE159253T1 (de) | 2-thiazolylpyrroleakrylate mit fungizider wirkung | |
TH14431EX (th) | อนุพันธ์ของกรดไฮดรอกซาลิค | |
TH13552EX (th) | อนุพันธุ์ต่าง ๆ ของเบนโซฟิโนน | |
TH16583A (th) | สารฆ่าวัชพืชชนิดใหม่ | |
TH20043A (th) | สารผสมฆ่าสัตว์ทำลาย | |
FI944414A0 (fi) | N-t-butyyli-androst-3,5-dieeni-17B-karboksamidi-3-karboksyylihapon polymorfi A | |
TH14587A (th) | อนุพันธ์แคมพ์โทธีซินที่ละลายน้ำได้ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |